drugset / Trial / NCT04167280

Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled Asthma

NCT04167280

Phase 4 Completed 12 enrolled University of Saskatchewan
RandomizedCrossoverTriple-blindTreatment

Summary

Study is looking at the development of tolerance to methacholine following regular use of ipratropium bromide in mild asthmatics.

Timeline

Start
2019-11-05
Primary completion
2020-03-13
Completion
2020-03-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ipratropium Small molecule 20 ug Inhaled

Indications